UBS Adjusts Price Target on Ralph Lauren to $521 From $520, Maintains Buy Rating
UBS has slightly increased its price target for Ralph Lauren Corporation while maintaining a Buy rating on the stock.
Stocks · News reference
Ralph Lauren and Other Major Companies File Lawsuit Against UnitedHealthcare Over 'Cross-Plan Offsetting'
Ralph Lauren Corporation is among a group of companies suing UnitedHealthcare (UHG) for allegedly engaging in 'cross-plan offsetting,' a practice they claim cost their health plans millions of dollars.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ralph Lauren Launches Polofest in Tokyo
Ralph Lauren has initiated a series of international events, beginning with Polofest in Tokyo, to celebrate the brand's history and upcoming 60th anniversary in 2027.
Deutsche Bank Adjusts Ralph Lauren Price Target to $452 From $446
Deutsche Bank has updated its price target for Ralph Lauren Corporation, raising it from $446 to $452.
JPMorgan Adjusts Price Target on Ralph Lauren to $464 From $463
JPMorgan has updated its price target for Ralph Lauren Corporation, raising it slightly from $463 to $464.